Advertising and Editorial Information
At Drug Target Review we offer a range of print and online advertising opportunities suited to all our customers needs. Our magazine and website are accessed by senior decision-makers in the pharmaceutical, life science and drug discovery industries at top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe. This represents a highly targeted advertising opportunity for companies, who wish to influence the key decision makers in what is a vitally important industry.
Reaching Your Audience
With industry events being cancelled and travel restrictions being put upon both companies and individuals, reaching your audience at this time has never been more difficult. This is where Drug Target Review can help you in reaching your audience and optimising your marketing budget.
|Print magazine circulation||9,150|
|Additional unique digital circulation||5,750|
|Email Third Party subscribers||31,407|
|Email Industry Insight subscribers||37,181|
|Email Enewsletter subscribers||33,038|
|Twitter followers [View Profile]||4,849|
|LinkedIn company page followers [View Profile]||11,518|
|LinkedIn group members [View Profile]||2,124|
|Facebook followers [View Profile]||798|
|Website average monthly unique users April 2020 – April 2021||128,276|
|Website average monthly page views April 2020 – April 2021||183,107|
Figures correct as of 9 April 2021
Strategically position your brand within the Drug Target Review network to put yourself in front of leaders in the drug discovery industry. With an audience of 9,150 ABC-audited print magazine readers, 33,038 enewsletter subscribers and 128,276 average unique monthly website visitors, our brand awareness opportunities enable you to reach valuable prospects, capture mindshare and encourage direct response. Drug Target Review offers a range of integrated marketing opportunities and a variety of campaign elements — print and digital ads, events, social media and more — that can be customised to meet your business goals.
Partner with Drug Target Review to showcase your expertise to elite drug discovery professionals. We will work alongside your marketing team to develop a multi-channel plan and create content that communicates your thought leadership, resonates in the marketplace and reaches your target audience. Distributing content through our unique network maximizes your reach, reinforces your position as a go-to provider and strengthens your influence within the market.
Highlight your product via direct response campaigns within the Drug Target Review network to educate prospects, drive engagement and secure business development opportunities. We will partner with you to identify the optimum mix of channels to deliver your message through a range of touch points — in-person at events, web and online communications, and more — to reach your business goals. Delivering tailored communications under the Drug Target Review brand to our engaged audience is critical to a successful demand generation campaign.
Advertising Tech Specs
Advertising Technical Specifications
Technical specifications for all advertising channels (print & digital) can be found here:
How to submit an article to Drug Target Review
If you are an end-user and are interested in submitting an article, please email the editor with your proposed topic and/or a brief synopsis.
Submitted articles should be high-level and topical, to interest a large number of industry professionals.
Articles can be written by up to five authors and will be complemented by your career biography and photograph – along with those of any co-authors.
Would you prefer to put your opinion across in a series of online articles? Click here to read some of the articles currently on Drug Target Review.
There is limited space available in print and on the website, so please try to indicate your interest as soon as possible.
For more information, please contact our Deputy Editor, Victoria Rees:
T: +44 (0)1959 563311
Notes for Authors
Editorial acceptance form
Before publishing your article, we must be in receipt of your signed acceptance form.
Articles should be written in the English language.
Please avoid commercial bias in the article. Only refer to individual products/processes if it is essential to support the technical content of the text.
Unless stated otherwise, your article should be around 1,200 – 1,600 words in length, not including captions or references.
References should be numbered and listed at the end of your copy.
Images, graphs and tables
Any digital images must be high resolution: at least 300 dpi and saved in either a JPEG or TIFF format as separate files, not embedded in a MS Word document or similar.
Author’s biography & photograph
Please supply a brief biography and high resolution (at least 300 dpi) photograph of the author(s) to accompany your article.
The publisher reserves the right to edit any article if necessary, whilst retaining its context.
We are not a peer-reviewed publication.
Once the article has been received by us, it is not our standard practice to send a proof back to the author prior to publication.
Your cooperation on these points will ensure that your article is included at the first available opportunity and reproduced to the highest possible standard.
If you have any further queries regarding the above, please contact the Deputy Editor, Victoria Rees, on +44 (0)1959 563311 or email [email protected].